Disseminated intravascular coagulopathy caused by Kikuchi-Fujimoto disease resulting in death: First case report in Turkey


Uslu E., Gurbuz S., Erden A., Aykas F., Karagoz H., Karahan S., ...Daha Fazla

International Medical Case Reports Journal, cilt.7, sa.1, ss.19-22, 2014 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7 Sayı: 1
  • Basım Tarihi: 2014
  • Doi Numarası: 10.2147/imcrj.s58891
  • Dergi Adı: International Medical Case Reports Journal
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.19-22
  • Anahtar Kelimeler: Disseminated intravascular coagulopathy, Kikuchi-Fujimoto disease, Necrotizing lymphadenitis
  • Ankara Üniversitesi Adresli: Evet

Özet

Kikuchi disease, also called Kikuchi-Fujimoto disease or Kikuchi's histiocytic necrotizing lymphadenitis, is a rare, benign condition of unknown cause, usually characterized by cervical lymphadenopathy and fever. The diagnosis is based on histopathology. Our patient was a woman with bilateral cervical lymphadenopathy, fever, chest and abdominal pain, fatigue, maculopapular rash on her face, trunk, and upper and lower extremities. Immunological and rheumatological tests were negative. We took a cervical lymph node biopsy that showed a proliferative and necrotizing process centered in the paracortex characterized by patchy circumscribed or confluent areas of necrosis associated with karyorrhexis, and was remarkable by the absence of granulocytes and the paucity of plasma cells. These findings confirmed the diagnosis of Kikuchi's disease. The patient's hemoglobin values decreased, and the peripheral blood smear revealed schistocytes. Blood tests showed raised D-dimer, activated partial thromboplastin time, prothrombin time, and international normalized ratio with decreased fibrinogen. The patient's condition quickly worsened and disseminated intravascular coagulopathy eventually developed. Her initial management consisted of a corticosteroid and hydroxychloroquine. © 2014 Uslu et al.